Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

RDY

Dr. Reddy's Laboratories Limited

Healthcare · USD

Set alert

Price alert · RDY

All alert types
14.17 USD +0.06 +0.43%
As of Oct 30, 2026 Extended hours 14.17 0.00%
Bid
14.17 × 3,800
Ask
14.18 × 4,200
14.15 Day range 14.29
11.38 52-week range 15.38
YTD
+0.93%
1 year
+5.35%
Open
14.20
Prev close
14.11
Mkt cap
11.80B
Vol
1.81M
Avg vol
2.93M
EPS
0.36
P/E
39.36
Div yield
0.59%
More statistics
Low
14.15
High
14.29
Forward P/E
21.39
Beta
0.25
Short ratio
8.16
Inst. own
14.93%
Dividend
0.08
Ex-div date
Jul 8, 2026
Earnings
Jan 22, 2027
50-d avg
12.50
200-d avg
13.21
1y target
14.31

5D chart

Chart tools
Interval
1m5m15m30m
RDY five-day price chart13.613.814.014.114.3Oct 26Oct 27Oct 28Oct 29Oct 30

Financial health

Altman Z-Score

5.55 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

5 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B+3 / 5 overall

  • DCF 3
  • Return on Equity 3
  • Return on Assets 4
  • Debt / Equity 3
  • P/E 2
  • P/B 3

Valuation

P/E 24.0×
FY 2017: 7.2×FY 2018: 7.1×FY 2019: 5.0×FY 2020: 5.2×FY 2021: 43.4×FY 2022: 29.8×FY 2023: 17.2×FY 2024: 18.4×FY 2025: 16.6×FY 2026: 24.0×
FY 2017 5y median 18.4× FY 2026
P/S 3.0×
FY 2017: 3.1×FY 2018: 2.5×FY 2019: 3.0×FY 2020: 2.9×FY 2021: 293×FY 2022: 3.3×FY 2023: 3.2×FY 2024: 3.7×FY 2025: 2.9×FY 2026: 3.0×
FY 2017 5y median 3.2× FY 2026
P/B 2.9×
FY 2017: 3.5×FY 2018: 2.8×FY 2019: 3.3×FY 2020: 248×FY 2021: 316×FY 2022: 3.7×FY 2023: 3.4×FY 2024: 3.7×FY 2025: 2.8×FY 2026: 2.9×
FY 2017 5y median 3.4× FY 2026
P/FCF 33.6×
FY 2017: -22.3×FY 2018: 50.1×FY 2019: 22.0×FY 2020: 21.4×FY 2021: 32.3×FY 2022: 77.7×FY 2023: 19.4×FY 2024: 57.1×FY 2025: 78.2×FY 2026: 33.6×
FY 2017 5y median 57.1× FY 2026
EV/EBITDA 13.7×
FY 2017: 18.9×FY 2018: 16.8×FY 2019: 14.2×FY 2020: 12.2×FY 2021: 56.9×FY 2022: 16.0×FY 2023: 10.5×FY 2024: 11.8×FY 2025: 10.1×FY 2026: 13.7×
FY 2017 5y median 11.8× FY 2026
EV/Sales 3.2×
FY 2017: 3.3×FY 2018: 2.8×FY 2019: 3.3×FY 2020: 2.9×FY 2021: 293×FY 2022: 3.4×FY 2023: 3.2×FY 2024: 3.7×FY 2025: 3.0×FY 2026: 3.2×
FY 2017 5y median 3.2× FY 2026
FCF Yield 3.0%
FY 2017: -4.5%FY 2018: 2.0%FY 2019: 4.5%FY 2020: 4.7%FY 2021: 3.1%FY 2022: 1.3%FY 2023: 5.2%FY 2024: 1.8%FY 2025: 1.3%FY 2026: 3.0%
FY 2017 5y median 1.8% FY 2026

Profitability

Gross Margin 52.8%
FY 2017: 55.6%FY 2018: 53.7%FY 2019: 54.2%FY 2020: 53.8%FY 2021: 50.8%FY 2022: 53.1%FY 2023: 56.7%FY 2024: 58.6%FY 2025: 58.5%FY 2026: 52.8%
FY 2017 5y median 56.7% FY 2026
Operating Margin 13.8%
FY 2017: 9.6%FY 2018: 8.4%FY 2019: 13.6%FY 2020: 9.2%FY 2021: 16.9%FY 2022: 13.7%FY 2023: 23.2%FY 2024: 24.3%FY 2025: 22.1%FY 2026: 13.8%
FY 2017 5y median 22.1% FY 2026
Net Margin 12.8%
FY 2017: 8.5%FY 2018: 6.9%FY 2019: 12.2%FY 2020: 11.2%FY 2021: 9.1%FY 2022: 11.0%FY 2023: 18.3%FY 2024: 19.9%FY 2025: 17.4%FY 2026: 12.8%
FY 2017 5y median 17.4% FY 2026
ROE 12.2%
FY 2017: 9.7%FY 2018: 7.8%FY 2019: 13.4%FY 2020: 951.7%FY 2021: 9.8%FY 2022: 12.4%FY 2023: 19.5%FY 2024: 19.8%FY 2025: 17.0%FY 2026: 12.2%
FY 2017 5y median 17.0% FY 2026
ROIC 8.1%
FY 2017: 6.2%FY 2018: 4.5%FY 2019: 9.6%FY 2020: 671.3%FY 2021: 10.0%FY 2022: 9.5%FY 2023: 17.2%FY 2024: 17.2%FY 2025: 13.3%FY 2026: 8.1%
FY 2017 5y median 13.3% FY 2026
ROA 7.9%
FY 2017: 5.5%FY 2018: 4.3%FY 2019: 8.3%FY 2020: 635.1%FY 2021: 6.4%FY 2022: 8.0%FY 2023: 14.0%FY 2024: 14.4%FY 2025: 11.5%FY 2026: 7.9%
FY 2017 5y median 11.5% FY 2026

Growth (YoY)

Revenue 8.6%
FY 2017: -9.0%FY 2018: 0.9%FY 2019: 8.3%FY 2020: 13.5%FY 2021: -98.5%FY 2022: 8288.8%FY 2023: 14.7%FY 2024: 13.5%FY 2025: 16.6%FY 2026: 8.6%
FY 2017 FY 2026
Operating Income -32.0%
FY 2017: -54.4%FY 2018: -11.7%FY 2019: 75.3%FY 2020: -23.4%FY 2021: -97.3%FY 2022: 6732.0%FY 2023: 93.9%FY 2024: 18.5%FY 2025: 6.1%FY 2026: -32.0%
FY 2017 FY 2026
EPS (diluted) -20.4%
FY 2017: -38.4%FY 2018: -18.1%FY 2019: 91.6%FY 2020: 3.8%FY 2021: -82.3%FY 2022: 36.7%FY 2023: 91.1%FY 2024: 23.3%FY 2025: 1.5%FY 2026: -20.4%
FY 2017 FY 2026
Free Cash Flow 166.8%
FY 2017: -173.8%FY 2018: 135.9%FY 2019: 203.7%FY 2020: 11.8%FY 2021: -2.5%FY 2022: -60.9%FY 2023: 341.6%FY 2024: -55.0%FY 2025: -33.2%FY 2026: 166.8%
FY 2017 FY 2026

Financial Health

Current Ratio 1.8×
FY 2017: 1.2×FY 2018: 1.6×FY 2019: 1.9×FY 2020: 1.8×FY 2021: 1.8×FY 2022: 1.9×FY 2023: 2.4×FY 2024: 2.6×FY 2025: 1.9×FY 2026: 1.8×
FY 2017 5y median 1.9× FY 2026
Quick Ratio 1.3×
FY 2017: 0.8×FY 2018: 1.2×FY 2019: 1.4×FY 2020: 1.3×FY 2021: 1.2×FY 2022: 1.4×FY 2023: 1.8×FY 2024: 1.9×FY 2025: 1.4×FY 2026: 1.3×
FY 2017 5y median 1.4× FY 2026
Debt / Equity 0.2×
FY 2017: 0.4×FY 2018: 0.4×FY 2019: 0.3×FY 2020: 0.1×FY 2021: 0.2×FY 2022: 0.2×FY 2023: 0.1×FY 2024: 0.1×FY 2025: 0.1×FY 2026: 0.2×
FY 2017 5y median 0.1× FY 2026
Net Debt / EBITDA 0.7×
FY 2017: 1.3×FY 2018: 2.0×FY 2019: 1.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.4×FY 2023: 0.1×FY 2024: 0.1×FY 2025: 0.3×FY 2026: 0.7×
FY 2017 5y median 0.3× FY 2026
Interest Coverage 12.4×
FY 2017: 21.3×FY 2018: 15.1×FY 2019: 23.5×FY 2020: 1154×FY 2021: 0.4×FY 2022: 30.8×FY 2023: 40.0×FY 2024: 39.6×FY 2025: 25.4×FY 2026: 12.4×
FY 2017 5y median 30.8× FY 2026

Dividends

Dividend Yield 0.7%
FY 2017: 0.8%FY 2018: 1.1%FY 2019: 0.9%FY 2020: 0.8%FY 2021: 0.6%FY 2022: 0.6%FY 2023: 0.6%FY 2024: 0.6%FY 2025: 0.7%FY 2026: 0.7%
FY 2017 5y median 0.6% FY 2026
Payout Ratio 15.5%
FY 2017: 28.2%FY 2018: 40.7%FY 2019: 21.3%FY 2020: 20.1%FY 2021: 1785.9%FY 2022: 17.6%FY 2023: 11.0%FY 2024: 11.9%FY 2025: 11.8%FY 2026: 15.5%
FY 2017 5y median 11.9% FY 2026

Annual · latest fiscal year ends 2026-03-31